Clinical-stage biotech PharmAust has submitted a request for orphan medicinal product designation (OMPD) to the European Medicines Agency (EMA) for...

An experimental mRNA cancer vaccine shows promising results in a Phase 1 trial, potentially offering new hope for advanced-stage cancer patients.

Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit from...

Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit from...

Experts hail ‘remarkable’ trial results for treatment of a form of skin cancer that once had grim prognosis

Can AI predict and prevent brain disorders like Alzheimer's? Yes! Discover how AI is transforming neurological care for a healthier future.

Young patients on psychiatric medications frequently receive potentially harmful drug combinations. Researchers examined New York State Medicaid...

LEHI, Utah., Sept. 12, 2024. Biolexis Therapeutics, a biopharmaceutical company pioneering next-generation weight loss treatments, today announced the...

Rocket completes enrollment of patients in a pivotal phase II study evaluating RP-A501 for treating male patients with Danon disease.

Data from a late-stage study shows that SMMT's experimental antibody beat Keytruda in a head-to-head setting in treating certain patients with NSCLC.